Literature DB >> 17559370

Possible involvement of cytokine gene polymorphisms in fulminant hepatitis.

Mihoko Takakura1, Katsutoshi Tokushige, Noriko Matsushita, Etsuko Hashimoto, Keiko Shiratori.   

Abstract

BACKGROUND AND AIM: Host genetic factors have been reported as influencing the progress to fulminant hepatitis (FH). Our previous data showed the serum level of tumor necrosis factor (TNF)-alpha influenced by gene polymorphisms to be markedly increased. It was investigated whether polymorphisms in the IL-10 gene, in addition to TNF-alpha and -beta gene polymorphisms, might contribute to the pathogenesis of FH.
METHODS: We analyzed 42 patients with FH, 78 patients with acute hepatitis (AH), and 149 healthy subjects (control). IL-10 polymorphism sites at promoter regions -1028, -819, -592; TNF-alpha polymorphism sites at promoter regions -1031, -863, -857, -308, -238; and TNF-beta first intron Nco1 sites were studied. IL-10 gene polymorphisms were classified into three groups: low IL-10-producing haplotypes (ATA/ATA), intermediate haplotypes (ATA or CCA/CCA), and high haplotypes (ATA/ATG or CCG).
RESULTS: The allelic frequency of B2 in the TNF-beta gene was significantly higher in FH patients compared with the control group. The three groups showed no differences in polymorphisms of positions -1031, -863, -857, -308 and -238 in the TNF-alpha gene. The frequency of low IL-10-producing haplotypes tended to be higher in FH patients compared with control and that of high IL-10-producing haplotype tended to be lower in FH patients compared with control. The carrier rate with both the IL-10 haplotype and the TNF-beta gene B2/B2 was significantly higher than control.
CONCLUSION: Variations of cytokine polymorphisms including IL-10 and TNF-beta genes may be attributable to the pathogenesis of FH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17559370     DOI: 10.1111/j.1440-1746.2007.04846.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

1.  Keratin variants predispose to acute liver failure and adverse outcome: race and ethnic associations.

Authors:  Pavel Strnad; Qin Zhou; Shinichiro Hanada; Laura C Lazzeroni; Bi Hui Zhong; Phillip So; Timothy J Davern; William M Lee; M Bishr Omary
Journal:  Gastroenterology       Date:  2010-06-09       Impact factor: 22.682

2.  Association of a single-nucleotide polymorphism within the miR-146a gene with susceptibility for acute-on-chronic hepatitis B liver failure.

Authors:  Huajun Jiang; Xingxing He; Jing Li; Qionghui Xie; Jusheng Lin; Ying Chang
Journal:  Immunogenetics       Date:  2013-01-06       Impact factor: 2.846

3.  Association of tumor necrosis factor-alpha gene promoter polymorphisms with acute viral hepatitis in the Indian population.

Authors:  Shashideep Singhal; Indu Kohaar; Mausumi Bharadwaj; Deepak K Shukla; Bhudev C Das; Premashis Kar
Journal:  Dig Dis Sci       Date:  2009-04-24       Impact factor: 3.199

4.  Tumor necrosis factor-alpha-induced reduction of glomerular filtration rate in rats with fulminant hepatic failure.

Authors:  Jing-Bo Wang; Dong-Lei Wang; Hai-Tao Wang; Zhao-Han Wang; Ying Wen; Cui-Ming Sun; Yi-Tong Zhao; Jian Wu; Pei Liu
Journal:  Lab Invest       Date:  2014-06-02       Impact factor: 5.662

5.  Association of IL-10 polymorphisms with hepatitis B virus infection and outcome in Han population.

Authors:  Lei Gao; Xi Chen; Lian Zhang; Di Wu; He Zhao; Junqi Niu
Journal:  Eur J Med Res       Date:  2016-06-01       Impact factor: 2.175

6.  Association of TNF-α Gene Polymorphisms with Production of Protein and Susceptibility to Chronic Hepatitis B Infection in the South East Iranian Population.

Authors:  Zahra Heidari; Bita Moudi; Hamidreza Mahmoudzadeh Sagheb; Mehrnoosh Moudi
Journal:  Hepat Mon       Date:  2016-10-30       Impact factor: 0.660

7.  The relationship between L-leucine-7-amido-4-methyl coumarin 1 gene polymorphism and susceptibility to the chronic hepatitis B virus infection in an Iranian population.

Authors:  Bita Moudi; Zahra Heidari; Hamidreza Mahmoudzadeh-Sagheb; Parisa Farrokh
Journal:  J Res Med Sci       Date:  2018-07-26       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.